FI860284A - Foerfarande foer diagnostisering av ledsjukdomar. - Google Patents
Foerfarande foer diagnostisering av ledsjukdomar. Download PDFInfo
- Publication number
- FI860284A FI860284A FI860284A FI860284A FI860284A FI 860284 A FI860284 A FI 860284A FI 860284 A FI860284 A FI 860284A FI 860284 A FI860284 A FI 860284A FI 860284 A FI860284 A FI 860284A
- Authority
- FI
- Finland
- Prior art keywords
- ledsjukdomar
- diagnostisering
- foerfarande foer
- galactose
- component
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/54—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving glucose or galactose
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/10—Musculoskeletal or connective tissue disorders
- G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
- G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/827—Lectins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Emergency Medicine (AREA)
- Rehabilitation Therapy (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Electroluminescent Light Sources (AREA)
- Vessels, Lead-In Wires, Accessory Apparatuses For Cathode-Ray Tubes (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/693,075 US4659659A (en) | 1985-01-22 | 1985-01-22 | Diagnostic method for diseases having an arthritic component |
US69307585 | 1985-01-22 |
Publications (4)
Publication Number | Publication Date |
---|---|
FI860284A0 FI860284A0 (fi) | 1986-01-21 |
FI860284A true FI860284A (fi) | 1986-07-23 |
FI88341B FI88341B (fi) | 1993-01-15 |
FI88341C FI88341C (fi) | 1993-04-26 |
Family
ID=24783210
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI860284A FI88341C (fi) | 1985-01-22 | 1986-01-21 | Foerfarande foer diagnostisering av ledgaongsinflammationer |
Country Status (14)
Country | Link |
---|---|
US (1) | US4659659A (fi) |
EP (1) | EP0189388B1 (fi) |
JP (1) | JP2515289B2 (fi) |
AT (1) | ATE78518T1 (fi) |
AU (1) | AU586662B2 (fi) |
CA (1) | CA1272670A (fi) |
DE (1) | DE3686061T2 (fi) |
DK (1) | DK164417C (fi) |
FI (1) | FI88341C (fi) |
GR (1) | GR860167B (fi) |
IE (1) | IE58727B1 (fi) |
IL (1) | IL77666A (fi) |
NO (1) | NO166302C (fi) |
ZA (1) | ZA86442B (fi) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4659659A (en) * | 1985-01-22 | 1987-04-21 | Monsanto Company | Diagnostic method for diseases having an arthritic component |
GB8618443D0 (en) * | 1986-07-29 | 1986-09-03 | Univ London | Monoclonal antibodies |
GB8714270D0 (en) * | 1987-06-18 | 1987-07-22 | Williams G R | Analysis of carbohydrates |
US4791067A (en) * | 1987-06-25 | 1988-12-13 | Fisher Scientific Co. | Agglutination immunoassay for hapten involving monoclonal antibody of IgA class reagent |
CA2016125A1 (en) * | 1989-05-19 | 1990-11-19 | Eisai Co., Ltd. | Diagnostic drug for rheumatoid arthritis |
US5089409A (en) * | 1989-09-28 | 1992-02-18 | Monsanto Company | Method of increasing specific activity of t-pa |
US5100778A (en) * | 1989-10-03 | 1992-03-31 | Monsanto Company | Oligosaccharide sequencing |
US5164374A (en) * | 1990-12-17 | 1992-11-17 | Monsanto Company | Use of oligosaccharides for treatment of arthritis |
JP3537535B2 (ja) * | 1994-07-14 | 2004-06-14 | 株式会社中埜酢店 | 免疫グロブリンg結合糖鎖構造に基づく臨床検査方法 |
US6159748A (en) * | 1995-03-13 | 2000-12-12 | Affinitech, Ltd | Evaluation of autoimmune diseases using a multiple parameter latex bead suspension and flow cytometry |
US5846758A (en) * | 1995-11-30 | 1998-12-08 | His Excellency Ghassan I. Shaker | Method for diagnosing autoimmune diseases |
IL129835A (en) * | 1999-05-06 | 2008-03-20 | Ofer Markman | Polysaccharide sequencing and structure determination |
US20040132131A1 (en) * | 2001-11-05 | 2004-07-08 | Ofer Markman | Methods for comparitive analysis of carbohydrate polymers and carbohydrate polymers identified using same |
US7407773B2 (en) * | 2000-11-03 | 2008-08-05 | Procognia, Ltd. | Method for characterizing a carbohydrate polymer |
EP1583968B1 (en) * | 2003-01-14 | 2015-04-22 | VIB, vzw | A serum marker for measuring liver fibrosis |
AU2004222345A1 (en) * | 2003-03-14 | 2004-09-30 | Ppd Biomarker Discovery Sciences, Llc | Biological markers for diagnosing rheumatoid arthritis |
WO2005015200A1 (ja) * | 2003-08-11 | 2005-02-17 | Shionogi Co., Ltd. | 血清を用いた簡易疾患診断およびテーラーメイド治療 |
WO2005059563A2 (en) * | 2003-12-18 | 2005-06-30 | Procognia Ltd. | Method for analyzing a glycomolecule |
WO2006007664A1 (en) * | 2004-07-22 | 2006-01-26 | Genomics Research Partners Pty Ltd | Agents and methods for diagnosing osteoarthritis |
US20060269979A1 (en) * | 2005-04-26 | 2006-11-30 | Dwek Raymond A | High throughput glycan analysis for diagnosing and monitoring rheumatoid arthritis and other autoimmune diseases |
US8039208B2 (en) * | 2005-04-26 | 2011-10-18 | National Institute For Bioprocessing Research And Training Limited (Nibrt) | Automated strategy for identifying physiological glycosylation markers(s) |
US7892752B2 (en) * | 2005-04-26 | 2011-02-22 | Dwek Raymond A | Glycosylation markers for cancer diagnosing and monitoring |
NZ569979A (en) * | 2005-06-10 | 2011-08-26 | Mannatech Inc | Rapid saccharide biomarker assay |
US20090181078A1 (en) | 2006-09-26 | 2009-07-16 | Infectious Disease Research Institute | Vaccine composition containing synthetic adjuvant |
US8273361B2 (en) | 2006-09-26 | 2012-09-25 | Infectious Disease Research Institute | Vaccine composition containing synthetic adjuvant |
US20100266558A1 (en) * | 2007-12-18 | 2010-10-21 | Dov Zipori | Method and assay for glycosylation pattern detection related to cell state of stem cells |
TWI494125B (zh) | 2009-06-05 | 2015-08-01 | Infectious Disease Res Inst | 合成的葡萄吡喃糖基脂質佐劑 |
US9044420B2 (en) | 2011-04-08 | 2015-06-02 | Immune Design Corp. | Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses |
CN104363892A (zh) | 2012-02-07 | 2015-02-18 | 传染性疾病研究院 | 包含tlr4激动剂的改进佐剂制剂及其使用方法 |
EP3388835B1 (en) | 2012-05-16 | 2020-04-01 | Immune Design Corp. | Vaccines for hsv-2 |
SG11201508092YA (en) | 2013-04-18 | 2015-10-29 | Immune Design Corp | Gla monotherapy for use in cancer treatment |
US9463198B2 (en) | 2013-06-04 | 2016-10-11 | Infectious Disease Research Institute | Compositions and methods for reducing or preventing metastasis |
KR20220100041A (ko) | 2013-12-31 | 2022-07-14 | 인펙셔스 디지즈 리서치 인스티튜트 (아이디알아이) | 단일 바이알 백신 제형 |
WO2017210364A1 (en) | 2016-06-01 | 2017-12-07 | Infectious Disease Research Institute | Nanoalum particles containing a sizing agent |
BR112021023726A2 (pt) | 2019-05-25 | 2022-02-15 | Infectious Disease Res Inst | Composição e método para secagem por pulverização de uma emulsão de vacina adjuvante |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3088875A (en) * | 1959-10-27 | 1963-05-07 | Hyland Lab | Immunological diagnostics utilizing polystyrene latex particles of 0.15 to 0.25 micron |
US4189466A (en) * | 1975-09-19 | 1980-02-19 | Technical Research Affiliates, Inc. | Detection of rheumatoid factor by antibody sensitized microbial particles |
US4213764A (en) * | 1978-08-09 | 1980-07-22 | Akzona Incorporated | Method for determining immunochemical substances |
US4282002A (en) * | 1979-09-06 | 1981-08-04 | Akzona Incorporated | Sensitized sheep stroma immunoassay for rheumatoid factor |
SE447028B (sv) * | 1980-06-30 | 1986-10-20 | Erik Audunn Cerven | Bestemning av endstaende sackaridgrupper i glykoprotein |
US4457865A (en) * | 1982-03-08 | 1984-07-03 | Research Corporation | Sialic acid specific slug lectin |
US4420461A (en) * | 1982-05-26 | 1983-12-13 | Ortho Diagnostic Systems Inc. | Agglutination-inhibition test kit for detecting immune complexes |
US4659659A (en) * | 1985-01-22 | 1987-04-21 | Monsanto Company | Diagnostic method for diseases having an arthritic component |
-
1985
- 1985-01-22 US US06/693,075 patent/US4659659A/en not_active Expired - Lifetime
-
1986
- 1986-01-21 AT AT86870007T patent/ATE78518T1/de not_active IP Right Cessation
- 1986-01-21 JP JP61010957A patent/JP2515289B2/ja not_active Expired - Lifetime
- 1986-01-21 EP EP86870007A patent/EP0189388B1/en not_active Expired - Lifetime
- 1986-01-21 FI FI860284A patent/FI88341C/fi not_active IP Right Cessation
- 1986-01-21 IL IL77666A patent/IL77666A/xx not_active IP Right Cessation
- 1986-01-21 NO NO860191A patent/NO166302C/no unknown
- 1986-01-21 DK DK029086A patent/DK164417C/da not_active IP Right Cessation
- 1986-01-21 GR GR860167A patent/GR860167B/el not_active IP Right Cessation
- 1986-01-21 CA CA000499994A patent/CA1272670A/en not_active Expired - Lifetime
- 1986-01-21 AU AU52538/86A patent/AU586662B2/en not_active Expired
- 1986-01-21 ZA ZA86442A patent/ZA86442B/xx unknown
- 1986-01-21 IE IE17686A patent/IE58727B1/en not_active IP Right Cessation
- 1986-01-21 DE DE8686870007T patent/DE3686061T2/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU5253886A (en) | 1986-07-31 |
NO860191L (no) | 1986-07-23 |
EP0189388A2 (en) | 1986-07-30 |
JP2515289B2 (ja) | 1996-07-10 |
FI88341C (fi) | 1993-04-26 |
JPS61170657A (ja) | 1986-08-01 |
AU586662B2 (en) | 1989-07-20 |
NO166302C (no) | 1991-06-26 |
US4659659A (en) | 1987-04-21 |
IE58727B1 (en) | 1993-11-03 |
DK29086A (da) | 1986-07-23 |
NO166302B (no) | 1991-03-18 |
ATE78518T1 (de) | 1992-08-15 |
EP0189388B1 (en) | 1992-07-22 |
DK164417C (da) | 1992-11-16 |
CA1272670C (en) | 1990-08-14 |
FI88341B (fi) | 1993-01-15 |
IL77666A (en) | 1990-12-23 |
GR860167B (en) | 1986-05-22 |
DK29086D0 (da) | 1986-01-21 |
CA1272670A (en) | 1990-08-14 |
ZA86442B (en) | 1986-10-29 |
EP0189388A3 (en) | 1988-11-30 |
FI860284A0 (fi) | 1986-01-21 |
DE3686061T2 (de) | 1993-03-11 |
DE3686061D1 (de) | 1992-08-27 |
IE860176L (en) | 1986-07-22 |
DK164417B (da) | 1992-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI860284A (fi) | Foerfarande foer diagnostisering av ledsjukdomar. | |
EP0644412A3 (de) | Verfahren zur Analyse klinisch relevanter Flüssigkeiten und Suspensionen. | |
ES2014540A6 (es) | Metodo para la determinacion de fragmentos peptidicos con un entrecruzamiento 3-hidroxipiridinio en un fluido corporal. | |
EP0419502A4 (en) | Method of detecting bacteria in urine | |
DE69636749D1 (de) | Methode zur bestimmung von proteinfragmenten in körperflüssigkeiten | |
AU7626787A (en) | Method of detecting or estimating biological material | |
AU2353188A (en) | A diagnostic agent and a method for the determination of apolipoprotein b | |
DE3163585D1 (en) | Method and reagent for the detection of fibrin monomer | |
FI922666A0 (fi) | Diagnostiskt foerfarande. | |
EP0217768A3 (en) | Method and compositions for heparin assays | |
IL115826A0 (en) | Use of erythropoietin in the treatment of rheumatoid arthritis | |
FI892536A0 (fi) | Menetelmä mykoplasmabakteerien laskemiseksi ja toteamiseksi | |
GR900100011A (en) | New diagnostic method | |
EP0170200A3 (en) | Breast cyst fluid screening method for cancer risk assessment | |
ATE269971T1 (de) | Verfahren zur prüfung von immunokompetenz | |
DE3572033D1 (en) | Method for diagnosis of a.i.d.s. | |
FR2574090B1 (fr) | Ensemble pour determiner la resistance intrinseque d'une famille de bacteries et methode de determination de cette resistance intrinseque | |
AU7692987A (en) | Reagent kit, its use and diagnostic process for the detection of hpasp(human pancreatic specific protein) | |
ES8500457A1 (es) | Un metodo para determinar la capacidad oxidante de un liquido biologico. | |
IT8767949A0 (it) | Sistema per il rilevamento e l analisi di parametri fisiologici nel campo della vestibologia della gastroenterologia e cardiologia | |
UA10243A (uk) | Спосіб диференційної діагностики вірусних гепатитів а і в у дітей | |
UA28862A (uk) | Спосіб визначення необхідності тестування на вілінфекцію |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB | Publication of examined application | ||
FG | Patent granted |
Owner name: MONSANTO COMPANY |
|
MA | Patent expired |